Drug
BL M14d1 And Atezolizumab
BL M14d1 And Atezolizumab: highest development phase Phase 3, developed by SystImmune Inc.. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- SystImmune Inc.
Trials
| Drug | Phase | Indication |
|---|---|---|
| BL-M14D1 and Atezolizumab NCT07625644 | Phase 3 | Small Cell Lung Cancer Extensive Stage |
Latest
No recent events.
Follow BL M14d1 And Atezolizumab on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.